A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA).
Cortesi L, Venturelli M, Cortesi G, Caggia F, Toss A, Barbieri E, De Giorgi U, Guarneri V, Musolino A, De Matteis E, Zambelli A, Bisagni G, Dominici M.
Cortesi L, et al. Among authors: bisagni g.
ESMO Open. 2023 Apr;8(2):101207. doi: 10.1016/j.esmoop.2023.101207. Epub 2023 Apr 5.
ESMO Open. 2023.
PMID: 37028000
Free PMC article.
Clinical Trial.